These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38553258)

  • 21. Future of the transdermal drug delivery market--have we barely touched the surface?
    Watkinson AC; Kearney MC; Quinn HL; Courtenay AJ; Donnelly RF
    Expert Opin Drug Deliv; 2016; 13(4):523-32. PubMed ID: 26646399
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Taro corms mucilage/HPMC based transdermal patch: an efficient device for delivery of diltiazem hydrochloride.
    Sarkar G; Saha NR; Roy I; Bhattacharyya A; Bose M; Mishra R; Rana D; Bhattacharjee D; Chattopadhyay D
    Int J Biol Macromol; 2014 May; 66():158-65. PubMed ID: 24556117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety Problems With a Transdermal Patch for Migraine: Lessons From the Development, Approval, and Marketing Process.
    Loder EW; Rayhill M; Burch RC
    Headache; 2018 Nov; 58(10):1639-1657. PubMed ID: 30367818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A systematic review of medication administration errors with transdermal patches.
    Lampert A; Seiberth J; Haefeli WE; Seidling HM
    Expert Opin Drug Saf; 2014 Aug; 13(8):1101-14. PubMed ID: 24921682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Laser facilitates week-long sustained transdermal drug delivery at high doses.
    Kakar P; Li Z; Li Y; Cao Y; Chen X
    J Control Release; 2020 Mar; 319():428-437. PubMed ID: 31923535
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transdermal delivery of drugs for the treatment of bone diseases.
    Ramachandran C; Fleisher D
    Adv Drug Deliv Rev; 2000 Aug; 42(3):197-223. PubMed ID: 10963836
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Age-related percutaneous penetration part 2: effect of age on dermatopharmacokinetics and overview of transdermal products.
    Konda S; Meier-Davis SR; Cayme B; Shudo J; Maibach HI
    Skin Therapy Lett; 2012 Jun; 17(6):5-7. PubMed ID: 22735504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analgesic patches and defibrillators: a cautionary tale.
    Brown MR; Denman R; Platts D
    Europace; 2009 Nov; 11(11):1552-3. PubMed ID: 19801566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Electrothermal patches driving the transdermal delivery of insulin.
    Pagneux Q; Ye R; Chengnan L; Barras A; Hennuyer N; Staels B; Caina D; Osses JIA; Abderrahmani A; Plaisance V; Pawlowski V; Boukherroub R; Melinte S; Szunerits S
    Nanoscale Horiz; 2020 Apr; 5(4):663-670. PubMed ID: 32226966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-Term Safety and Efficacy of Blonanserin Transdermal Patches in Japanese Patients with Schizophrenia: A 52-Week Open-Label, Multicenter Study.
    Iwata N; Ishigooka J; Naoi I; Matsumoto M; Kanamori Y; Nakamura H; Higuchi T
    CNS Drugs; 2020 Jan; 34(1):103-116. PubMed ID: 31883082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ternary Deep Eutectic Solvents System of Colchicine, 4-Hydroxyacetophenone, and Protocatechuic Acid and Characterization of Transdermal Enhancement Mechanism.
    Piao H; Xie W; Li S; Wang J; Liu C; Quan P; Fang L
    AAPS PharmSciTech; 2023 Nov; 24(8):229. PubMed ID: 37964102
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nanoparticle-Enabled Transdermal Drug Delivery Systems for Enhanced Dose Control and Tissue Targeting.
    Palmer BC; DeLouise LA
    Molecules; 2016 Dec; 21(12):. PubMed ID: 27983701
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bioadhesive film for dermal and transdermal drug delivery.
    Padula C; Nicoli S; Aversa V; Colombo P; Falson F; Pirot F; Santi P
    Eur J Dermatol; 2007; 17(4):309-12. PubMed ID: 17540637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Touch-actuated microneedle array patch for closed-loop transdermal drug delivery.
    Yang J; Chen Z; Ye R; Li J; Lin Y; Gao J; Ren L; Liu B; Jiang L
    Drug Deliv; 2018 Nov; 25(1):1728-1739. PubMed ID: 30182757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FDA warning: remove drug patches before MRI to prevent burns to skin.
    Kuehn BM
    JAMA; 2009 Apr; 301(13):1328. PubMed ID: 19336702
    [No Abstract]   [Full Text] [Related]  

  • 36. Fast-drying multi-laminate bioadhesive films for transdermal and topical drug delivery.
    Donnelly RF; McCarron PA; Morrow DI; Woolfson AD
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1818-31. PubMed ID: 23167263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimizing transdermal drug therapy.
    Ball AM; Smith KM
    Am J Health Syst Pharm; 2008 Jul; 65(14):1337-46. PubMed ID: 18593680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The influence of microwave radiation on transdermal delivery systems.
    Moseley H; Johnston S; Allen A
    Br J Dermatol; 1990 Mar; 122(3):361-3. PubMed ID: 2322499
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improved patient acceptability with a transdermal drug-in-adhesive oestradiol patch.
    Lake Y; Pinnock S
    Aust N Z J Obstet Gynaecol; 2000 Aug; 40(3):313-6. PubMed ID: 11065040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. On the Road to Development of an in Vitro Permeation Test (IVPT) Model to Compare Heat Effects on Transdermal Delivery Systems: Exploratory Studies with Nicotine and Fentanyl.
    Shin SH; Ghosh P; Newman B; Hammell DC; Raney SG; Hassan HE; Stinchcomb AL
    Pharm Res; 2017 Sep; 34(9):1817-1830. PubMed ID: 28608140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.